Key result
Curative NSCLC resection in geriatric patients carries ~5% 30-day mortality and low long-term survival.
Why the study?
What are the clinical outcomes and predictors of survival in geriatric patients undergoing curative resection for non-small cell lung carcinoma?
Cohort (n=273)
What are the clinical outcomes and predictors of survival in geriatric patients undergoing curative resection for non-small cell lung carcinoma?
Properly selected geriatric patients with stage I-II NSCLC can undergo surgical resection safely with acceptable morbidity and long-term survival, though extended resections carry higher early mortality risk.
Supports resection consideration in selected geriatric NSCLC patients; leaves open randomized validation of predictors and risks.
The purpose of this study was to determine clinical patterns, trends of outcome and survival in elderly patients with surgery for non-small cell lung carcinoma (NSCLC). Methods: 273 patients aged over 70 years who underwent curative resection for NSCLC, from 1995 to 2005, were followed-up. Analysis was performed with respect to preoperative conditions, surgery, histology, morbidity, mortality, and length of survival. Results: Mean age was 73.2±3.1 years. 31 (11.3%) patients were older than 80 years, consisting of 170 (62.2%) males, with a mean follow-up of 31 months. Most patients (n=237) received standard procedures: 200 bi- and lobectomies, 42 pneumonectomies, 9 sleeve resections and 22 wedge resections. 36 patients underwent extended resections for tumors involving, the chest wall (n=25), mediastinum (n=7) and pericardium (n=4). Thirty-day mortality was 5.4% with 25.9% developing pulmonary and 5.3% major cardiovascular complications. Multivariate analysis showed that extended procedures (p=0.0001), male gender (p=0.0001), low FEV1 (p=0.02) and age (p=0.02) were independent predictors of early mortality. Overall survival rates at 5 and 10 years were 35.6% and 10.5% respectively. Multivariate analysis showed that advanced disease stage (p=0.0001), low FEV1 (p=0.003), previous cardiac disease (p=0.01) and hypertension (p=0.03) were independent predictors which influenced survival. Conclusions: Properly selected geriatric patients with stage I–II NSCLC can be resected safely with acceptable morbidity and long-term survival. Substantial survival rates may also be achieved in stage IIIA patients in the absence of a macroscopically N2 disease. Lobectomy is the procedure of choice, extended resections should only be carried out in highly selected patients.
No takes yet. Share an insight, caveat, or question.
Sı̂rbu et al. (2007) conducted a cohort in non-small cell lung carcinoma (NSCLC) (n=273). Curative resection was evaluated on 30-day mortality. In geriatric patients undergoing curative resection for NSCLC, 30-day mortality was 5.4%, and overall survival rates at 5 and 10 years were 35.6% and 10.5%, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: